Researchers from the University of Oxford announced on Thursday that they have developed the first genetic test for predicting the likelihood that a patient’s colon cancer will recur. The test, which scans for mutations in 12 genes expressed by colon tumors, can tell patients in the early stages of colon cancer the chances that their disease will come back after treatment.
